1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Time intervals and outcome for CTP and non-CTP sites
CTP Sitesa (20 Sites/266 Subjects)Non-CTP Sites (38 Sites/382 Subjects)
ED to IV tPA initiationb (median) (IQR)63 (47.5–76)63 (49–87)
ED to groin puncturec (median)145 (122.5–176)157 (128–185)
90-Day mRS 0–2 (No.) (%)114 (42.9%)146 (38.2%)
  • Note:—IQR indicates interquartile range.
  • ↵a Sites that performed at least 1 baseline CTP.
  • ↵b Two subjects were missing from the CTP sites; 4 subjects were missing from the non-CTP sites.
  • ↵c Applicable only to subjects with groin puncture: 172 subjects from the CTP sites, 249 subjects from the non-CTP sites.